Nasdaq · CIK 0002091349
TRAX First Tracks Biotherapeutics, Inc.
Insider trading from SEC Form 4. Last filing 25 d ago. Close $31.85 on Oct 9, 2026, +108% from the 52-week low and -34% from the high.
Last 90 days
Net insider value
-$1.8M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$1.8M by 1 insider
Insiders on file
2
with a Form 4 at this company
Price and insider trades, last year
TRAXOct 9, 2026 · close 31.85
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at First Tracks Biotherapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | J. Anthony Ware director sell | $1.8M 39,265 shares | -71% | - |
Transactions
The last 6 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | John A Orwin director | MOption exercise Common Stock | +1,300 | $0.00 | $0 | 17,995 | 25 d ago |
| Sep 15, 2026 | John A Orwin director | MOption exercise Restricted Stock Unitderivative | -1,300 | $0.00 | $0 | 0 | 25 d ago |
| Sep 2, 2026 | J. Anthony Ware director | MOption exercise Common Stock | +39,265 | $5.74 | $225k | 54,925 | 38 d ago |
| Sep 2, 2026 | J. Anthony Ware director | SOpen-market sale Common Stock | -39,265 | $44.78 | $1.8M | 15,660 | 38 d ago |
| Sep 2, 2026 | J. Anthony Ware director | MOption exercise Stock Option (right to buy)derivative | -28,571 | $0.00 | $0 | 0 | 38 d ago |
| Sep 2, 2026 | J. Anthony Ware director | MOption exercise Stock Option (right to buy)derivative | -10,694 | $0.00 | $0 | 0 | 38 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.